Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Next Renewal Deadline
1168 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-09-18)
Due Date
September 18, 2028
Grace Period Ends
March 18, 2029
Application History
37 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 11, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Jan 2, 2025 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
Jan 2, 2025 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Jan 2, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Aug 2, 2024 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
Sep 18, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Sep 18, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Aug 15, 2018 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Aug 14, 2018 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Aug 6, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Aug 6, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Jul 11, 2018 | IUAF | S | USE AMENDMENT FILED |
Jul 11, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Apr 10, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Apr 6, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED |
Apr 6, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 6, 2018 | EXT2 | S | SOU EXTENSION 2 FILED |
Sep 16, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Sep 14, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED |
Sep 14, 2017 | EXT1 | S | SOU EXTENSION 1 FILED |
Sep 14, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 11, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Feb 28, 2017 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
Sep 13, 2016 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
Aug 16, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Aug 16, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 27, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jul 14, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jul 8, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jul 8, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jul 8, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jan 12, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jan 12, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jan 12, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jan 11, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
Sep 29, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Sep 26, 2015 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
anti-inflammatories; cardiovascular pharmaceuticals; [ pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders; ] pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; [ pharmaceutical preparations for the prevention and treatment of pruritus; ] pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare diseases and disorders
First Use Anywhere:
Nov 15, 2017
First Use in Commerce:
Nov 15, 2017
Additional Information
Translation
The wording "KINIKSA" has no meaning in a foreign language.
Classification
International Classes
005